Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
European Psychiatry : the Journal of the Association of European Psychiatrists|July 16, 2005
Are eye movement abnormalities indicators of genetic vulnerability to schizophrenia?C Boudet, M L Bocca, B Chabot, et al.
L'Encephale|November 1, 1992
[Platelet serotonin in infantile autism. Cross-over effects of a dopamine agonist and an antagonist]S Dollfus, M Petit, J M Launay, et al.
Journal of Child and Adolescent Psychopharmacology|July 28, 2009
Catecholamines in autistic disorder: effects of amisulpride and bromocriptine in a controlled crossover studyS Dollfus, M Petit, J P Garnier, et al.
L'Encephale|March 1, 1994
[Polydiagnostic approach to schizophrenia. Validation of a computerized checklist (Diagnostic and Prognostic Scales)]S Dollfus, M Petit, J F Ménard, et al.
L'Encephale|February 28, 2002
[Eye tracking disorders in schizophrenic patients and their parents]C Boudet, P Denise, M L Bocca, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 13, 2024
Effects of web-based adapted physical activity on hippocampal plasticity, cardiorespiratory fitness, symptoms, and cardiometabolic markers in patients with schizophrenia: a randomized, controlled studyE Leroux, M Tréhout, E Reboursiere, et al.
Schizophrenia Research|April 29, 1998
No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patientsF Thibaut, B Coron, D Hannequin, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 26, 1999
Apolipoprotein E-varepsilon4 frequency in deficit schizophreniaF Thibaut, A Van Der Elst, D Campion, et al.
Psychiatry Research|March 1, 1994
Genetic study of dopamine D1, D2, and D4 receptors in schizophreniaD Campion, T d'Amato, C Bastard, et al.
L'Encephale|December 3, 2017
[Validation of the French version of the self-evaluation of negative symptoms (SNS)]C Hervochon, V Bourgeois, M Rotharmel, et al.
Pageof 9